St. Gallen March 11-14, 2009 Roma 11 Giugno 2009 Teresa Gamucci Oncologia Medica Sora (FR)
Welcome! Please take a moment to complete the short in your packet. Your participation will help us assess the effectiveness of this program and shape.
Challenges and Success: Treatment of Metastatic Breast Cancer 2012 Hope S. Rugo University of California San Francisco Helen Diller Family Comprehensive.
Infusional 5-FU/FA plus Oxaliplatin (FUFOX) vs. Capecitabine plus Oxaliplatin (CAPOX) as first-line treatment for metastatic colorectal cancer: safety.
Cáncer de pulmón
0920 Vergote - Role of Radical Surgery PDF
Ovarian Cancer: Standards of Care and New Opportunities Robert L. Coleman, M.D. Professor & Vice Chair, Clinical Research Department of Gynecologic Oncology.
Marius M Hoeper The use of ERA after SERAPHIN, COMPASS-2 and AMBITION.
A Report from ASCO 2007 Adjuvant Colorectal Cancer John L. Marshall, MD Chief, Division of Hematology/Oncology Associate Director of Clinical Research.
Clinical Case Nº2 Dr. Javier Martín-Broto. Case description 49-year-old man 1 st symptom/sign: Mild pain in right buttock 1 st diagnosis: Core-biopsy:
1. 2 Learning Objectives After taking part in this activity, participants should be better able to: –Assess the significant clinical consequences and.
Optimizing Treatment for Her 2 Positive Metastatic Breast Cancer Patients Sunil Verma MD, MSEd, FRCPC Medical Oncologist Chair, Breast Medical Oncology.
